58.0BMMay 21
Atom-level Protein Representation Learning Improves Protein Structure PredictionTaewon Kim, Hyosoon Jang, Hyunjin Seo et al.
Recent advances in generative modeling show that pretrained representations can improve generation as conditioning features or alignment targets. Motivated by this, we study protein representations for predicting structures beyond conventional function annotation. We propose TriProRep, a structure-aware pretraining method that jointly models three aligned residue-level views: amino-acid identity, backbone geometry, and local full-atom geometry, discretely encoded via VQ-VAE tokenizers. By pretraining to recover original tokens from generator-corrupted views, TriProRep learns to distinguish plausible but incorrect cross-view augmentations from the original protein. We further introduce RepSP, a benchmark for evaluating protein representations in structure-predictive settings. RepSP tests three uses of representations: homodimer co-folding from apo-chain representations, residue-level prediction of homodimer-derived interaction properties, and representation-aligned monomer structure prediction. Across these tasks, TriProRep improves over sequence-only and prior structure-aware representation models, while maintaining competitive performance on conventional benchmarks.
BMOct 1, 2023
PharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore ModelingSeonghwan Seo, Woo Youn Kim
As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid screening, but there is still a lack of structure-based methods applicable to various proteins that perform protein-ligand binding conformation prediction and scoring in an extremely short time. Here, we describe for the first time a deep-learning framework for structure-based pharmacophore modeling to address this challenge. We frame pharmacophore modeling as an instance segmentation problem to determine each protein hotspot and the location of corresponding pharmacophores, and protein-ligand binding pose prediction as a graph-matching problem. PharmacoNet is significantly faster than state-of-the-art structure-based approaches, yet reasonably accurate with a simple scoring function. Furthermore, we show the promising result that PharmacoNet effectively retains hit candidates even under the high pre-screening filtration rates. Overall, our study uncovers the hitherto untapped potential of a pharmacophore modeling approach in deep learning-based drug discovery.
LGOct 5, 2023
TacoGFN: Target-conditioned GFlowNet for Structure-based Drug DesignTony Shen, Seonghwan Seo, Grayson Lee et al.
Searching the vast chemical space for drug-like molecules that bind with a protein pocket is a challenging task in drug discovery. Recently, structure-based generative models have been introduced which promise to be more efficient by learning to generate molecules for any given protein structure. However, since they learn the distribution of a limited protein-ligand complex dataset, structure-based methods do not yet outperform optimization-based methods that generate binding molecules for just one pocket. To overcome limitations on data while leveraging learning across protein targets, we choose to model the reward distribution conditioned on pocket structure, instead of the training data distribution. We design TacoGFN, a novel GFlowNet-based approach for structure-based drug design, which can generate molecules conditioned on any protein pocket structure with probabilities proportional to its affinity and property rewards. In the generative setting for CrossDocked2020 benchmark, TacoGFN attains a state-of-the-art success rate of $56.0\%$ and $-8.44$ kcal/mol in median Vina Dock score while improving the generation time by multiple orders of magnitude. Fine-tuning TacoGFN further improves the median Vina Dock score to $-10.93$ kcal/mol and the success rate to $88.8\%$, outperforming all optimization-based methods.
LGApr 10, 2025
Compositional Flows for 3D Molecule and Synthesis Pathway Co-designTony Shen, Seonghwan Seo, Ross Irwin et al.
Many generative applications, such as synthesis-based 3D molecular design, involve constructing compositional objects with continuous features. Here, we introduce Compositional Generative Flows (CGFlow), a novel framework that extends flow matching to generate objects in compositional steps while modeling continuous states. Our key insight is that modeling compositional state transitions can be formulated as a straightforward extension of the flow matching interpolation process. We further build upon the theoretical foundations of generative flow networks (GFlowNets), enabling reward-guided sampling of compositional structures. We apply CGFlow to synthesizable drug design by jointly designing the molecule's synthetic pathway with its 3D binding pose. Our approach achieves state-of-the-art binding affinity on all 15 targets from the LIT-PCBA benchmark, and 5.8$\times$ improvement in sampling efficiency compared to 2D synthesis-based baseline. To our best knowledge, our method is also the first to achieve state of-art-performance in both Vina Dock (-9.38) and AiZynth success rate (62.2\%) on the CrossDocked benchmark.
LGNov 25, 2021
Fragment-based molecular generative model with high generalization ability and synthetic accessibilitySeonghwan Seo, Jaechang Lim, Woo Youn Kim
Deep generative models are attracting great attention for molecular design with desired properties. Most existing models generate molecules by sequentially adding atoms. This often renders generated molecules with less correlation with target properties and low synthetic accessibility. Molecular fragments such as functional groups are more closely related to molecular properties and synthetic accessibility than atoms. Here, we propose a fragment-based molecular generative model which designs new molecules with target properties by sequentially adding molecular fragments to any given starting molecule. A key feature of our model is a high generalization ability in terms of property control and fragment types. The former becomes possible by learning the contribution of individual fragments to the target properties in an auto-regressive manner. For the latter, we used a deep neural network that predicts the bonding probability of two molecules from the embedding vectors of the two molecules as input. The high synthetic accessibility of the generated molecules is implicitly considered while preparing the fragment library with the BRICS decomposition method. We show that the model can generate molecules with the simultaneous control of multiple target properties at a high success rate. It also works equally well with unseen fragments even in the property range where the training data is rare, verifying the high generalization ability. As a practical application, we demonstrated that the model can generate potential inhibitors with high binding affinities against the 3CL protease of SARS-COV-2 in terms of docking score.